Fundz

Franklin Biolabs Names Vatsala Naageshwaran as Chief Executive Officer

PRIVATEDec 04, 2024

Position

Chief Executive Officer

Company

Franklin Biolabs

Vatsala Naageshwaran
vatsala.naageshwaran@franklinbio.com
King Of PrussiaBiotechnologyHealth CareGeneticsTherapeutics

Description

Franklin Biolabs has named Vatsala Naageshwaran, PhD, an award-winning biopharmaceutical executive, as the Chief Executive Officer. Dr. Naageshwaran brings deep experience driving scientific results and business growth, with a commitment to progressing advanced therapies for patients.

Company Information

Company

Franklin Biolabs

Location

King Of Prussia, Pennsylvania, United States

About

Franklin Biolabs is a genetic medicines focused contract research organization (CRO) founded by gene therapy pioneer James Wilson, MD, PhD. They are redefining the landscape of the global genetic medicines industry, with a focus on gene therapy, by providing a full range of services from discovery to clinical vect.

Fundz sees it the moment Franklin Biolabs changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Matthew
Likely contact at this company
••••••••@••••••••

See Matthew's verified email →

Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

Vatsala
Likely contact at this company
••••••••@••••••••

See Vatsala's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Franklin Biolabs's next move

Learn about Strategic plan

Franklin Biolabs changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.